唾液腺感染疾病市场规模、份额和成长分析（按感染疾病类型、受累腺体、诊断方法、治疗方法方法、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，全球唾液腺感染疾病市场规模将达到 64.4 亿美元，到 2025 年将成长至 70.2 亿美元，到 2033 年将成长至 141 亿美元，预测期（2026-2033 年）的复合年增长率为 9.1%。

受多种因素影响，全球唾液腺感染疾病市场正经历显着成长。口腔感染疾病率的上升，尤其是在老年人，推动了对有效治疗方法的需求不断增长。唾液腺内视镜和先进影像技术等诊断工具的创新，提高了早期发现感染的能力，从而改善了患者的治疗效果。大众对口腔健康问题的日益关注，促使患者倾向于选择微创治疗方法。此外，已开发国家医疗基础设施的改善以及新兴市场医疗服务可近性的提高，使得及时干预成为可能。这些趋势不仅推动了市场扩张，也促进了唾液腺感染疾病治疗方法和预防策略的进步，重塑了市场竞争格局。

全球唾液腺感染疾病市场驱动因素

口腔感染疾病（包括细菌性涎腺炎和病毒性腮腺炎）的日益增多，显着推动了全球唾液腺感染疾病治疗市场的需求成长。口腔卫生不良、人口老化以及糖尿病等潜在疾病等因素进一步加剧了这个问题。随着大众对这些感染疾病的认识不断提高，寻求及时医疗干预的患者数量也显着增加。这一趋势迫使医疗系统更加重视唾液腺疾病的早期诊断和专业治疗方案，最终重塑了市场格局。

全球唾液腺感染疾病市场限制因素

全球唾液腺感染疾病市场面临严峻挑战，主要原因是农村和医疗资源匮乏地区对疾病的认知度较低。这种认知不足阻碍了早期诊断和适当治疗，导致患者对症状的解读和寻求专科治疗的方式不一致。这造成了病例漏报和感染疾病治疗延误，阻碍了医疗服务的公平取得。这个问题严重限制了市场的整体成长潜力，凸显了加强教育和宣传活动以提高患者认知和加速治疗的必要性。

全球唾液腺感染疾病市场趋势

唾液腺镜检查等微创诊断技术的应用已成为全球唾液腺感染疾病市场的一大趋势。这些先进的诊疗手段在提高诊断准确性的同时，最大限度地减少了患者的不适感，并缩短了恢復时间。随着医疗机构越来越多地将这些技术应用于临床实践，对高效且便利的诊断方案的需求预计将推动市场显着成长和创新。这项转变不仅反映了医疗产业对微创诊疗的普遍偏好，也标誌着唾液腺感染疾病治疗领域变革时期时期，有助于改善病患的治疗效果和满意度。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球唾液腺感染疾病市场规模（按感染疾病类型和复合年增长率划分）（2026-2033 年）

• 细菌感染疾病
• 病毒感染疾病
• 霉菌感染疾病
• 寄生虫感染疾病

全球唾液腺感染疾病市场规模（依受累腺体划分）及复合年增长率（2026-2033 年）

• 腮腺感染疾病
• 下颔腺感染疾病
• 舌下腺感染疾病
• 小唾液腺感染疾病

全球唾液腺感染疾病市场规模（按诊断方法和复合年增长率划分）（2026-2033 年）

• 身体检查
• 诊断影像技术
• 检查室检测
• 切片检查/造影

全球唾液腺感染疾病市场规模（按治疗方法和复合年增长率划分）（2026-2033 年）

• 药物治疗
• 外科手术
• 抽吸/引流
• 居家照护/辅助护理

全球唾液腺感染疾病市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院和诊所
• 门诊手术中心
• 口腔颚颜面外科诊所
• 居家医疗/远端医疗

全球唾液腺感染疾病市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• AbbVie Inc.
• Allergan
• AstraZeneca
• FUJIFILM Holdings Corporation
• GlaxoSmithKline plc.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Siemens Healthcare GmbH
• General Electric Company（GE Healthcare）
• Roche Holding AG
• Takeda Pharmaceutical Company
• Stryker Corporation
• Zimmer Biomet Holdings
• Philips Healthcare
• Canon Medical Systems Corporation
• Hologic Inc.
• Olympus Corporation
• BD
• Varian Medical Systems

结论与建议

Global Salivary Gland Infection Market size was valued at USD 6.44 Billion in 2024 and is poised to grow from USD 7.02 Billion in 2025 to USD 14.1 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global salivary gland infection market is experiencing significant growth due to several influential factors. The rising incidence of oral infections, particularly among older populations, underscores the increasing demand for effective treatment options. Innovations in diagnostic tools such as sialendoscopy and advanced imaging techniques are enhancing early detection capabilities and improving patient outcomes. Growing public awareness about oral health issues is shifting patient preferences toward less invasive treatment modalities. Moreover, improved healthcare infrastructure in developed nations, coupled with enhanced access to medical services in emerging markets, is facilitating timely intervention. Collectively, these dynamics are not only propelling market expansion but also driving advancements in treatment and preventive strategies within the salivary gland infection sector, reshaping its competitive landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Salivary Gland Infection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Salivary Gland Infection Market Segments Analysis

Global Salivary Gland Infection Market is segmented by Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User and region. Based on Type of Infection, the market is segmented into Bacterial Infections, Viral Infections, Fungal Infections and Parasitic Infections. Based on Gland Affected, the market is segmented into Parotid Gland Infections, Submandibular Gland Infections, Sublingual Gland Infections and Minor Salivary Gland Infections. Based on Diagnosis Method, the market is segmented into Physical Examination, Imaging Techniques, Laboratory Testing and Biopsy / Sialography. Based on Treatment Type, the market is segmented into Medication, Surgical Procedures, Aspiration / Drainage and Home Care / Supportive Therapy. Based on End-User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Oral & Maxillofacial Clinics and Home Care / Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Salivary Gland Infection Market

The growing prevalence of oral infections, including bacterial sialadenitis and viral parotitis, significantly fuels the demand for treatment in the global salivary gland infection market. Contributing factors such as poor oral hygiene, advancing age, and underlying systemic health conditions like diabetes exacerbate this issue. As public awareness around these infections increases, there is a notable rise in patients seeking timely medical intervention. This trend compels healthcare systems to enhance their focus on early diagnosis and specialized treatment options for salivary gland disorders, ultimately shaping the landscape of care in the market.

Restraints in the Global Salivary Gland Infection Market

The Global Salivary Gland Infection market faces significant challenges due to the low awareness of these conditions in rural and underserved areas. This lack of awareness hinders early diagnosis and timely treatment, contributing to discrepancies in how patients interpret symptoms and seek specialist care. As a result, there is often underreporting of incidents and delays in addressing the infections, which poses a barrier to equitable healthcare access. This issue presents a considerable obstacle to the overall growth potential within the market, highlighting the need for improved education and outreach to enhance patient understanding and prompt treatment.

Market Trends of the Global Salivary Gland Infection Market

The Global Salivary Gland Infection market is witnessing a significant trend towards the adoption of minimally invasive diagnostic techniques, such as sialendoscopy. These advanced methods enhance diagnostic accuracy while minimizing patient discomfort and facilitating quicker recovery times. As healthcare providers increasingly integrate these technologies into their clinical practices, the demand for efficient and patient-friendly diagnostic options is expected to drive substantial growth and innovation within the market. This shift not only reflects a broader preference for less invasive procedures in healthcare but also indicates a transformative phase for the management of salivary gland infections, fostering improved patient outcomes and satisfaction.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Salivary Gland Infection Market Size by Type of Infection & CAGR (2026-2033)

• Market Overview
• Bacterial Infections
• Viral Infections
• Fungal Infections
• Parasitic Infections

Global Salivary Gland Infection Market Size by Gland Affected & CAGR (2026-2033)

• Market Overview
• Parotid Gland Infections
• Submandibular Gland Infections
• Sublingual Gland Infections
• Minor Salivary Gland Infections

Global Salivary Gland Infection Market Size by Diagnosis Method & CAGR (2026-2033)

• Market Overview
• Physical Examination
• Imaging Techniques
• Laboratory Testing
• Biopsy / Sialography

Global Salivary Gland Infection Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Medication
• Surgical Procedures
• Aspiration / Drainage
• Home Care / Supportive Therapy

Global Salivary Gland Infection Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Oral & Maxillofacial Clinics
• Home Care / Telemedicine

Global Salivary Gland Infection Market Size & CAGR (2026-2033)

• North America (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • US
  • Canada
• Europe (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (GE Healthcare)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations